Change over period: —
NSE · LXCHEM
LXCHEM
-24.8% from the 52-week high · +39.5% above the low
Laxmi Organic Industries Ltd. engages in the manufacture of acetyl and specialty intermediates. The company is headquartered in Mumbai, Maharashtra and currently employs 874 full-time employees. The company went IPO on 2021-03-25. The firm manufactures ethyl acetate, acetic acid and diketene derivative products (DDP). Its business segments include Acetyl Intermediates and Speciality Intermediates. The Acetyl Intermediates segment produces a range of acetyl products, including Bulk Solvents and Aldehydes. The firm manufactures a range of Acetyl products, including bulk solvents and aldehydes. Its acetyl products have applications in diverse industries, such as pharmaceutical formulations, printing inks, adhesives, coatings. The company is also a manufacturer of Speciality Intermediates, such as Ketene & Diketene derivatives, including Esters, Amides and Arylides. Its Speciality Intermediates has applications in pharmaceuticals, synthesis and manufacturing of agrochemicals, pigments, and others. The company also offers custom synthesis of Diketene Derivative Chemicals and Crop and Life Science Intermediates.
The short version. LXCHEM reported revenue of ₹1,083 crore for Sep 2026, up 54.7% from a year earlier. Net profit was ₹57 crore (up 418.2% year on year). Return on equity was 4.0% in Mar 2026. Promoter holding was 69.16% in Sep 2026, down 0.22 points over 8 quarters.
1 · The price
How has the stock traded?
LXCHEM trades 24.8% below its 52-week high and 39.5% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹1,083 cr.
Sep 2026 net profit of ₹57 cr.
3.7 pts higher than a year earlier.
Revenue compounded at 0.6% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1083 | 968 | 735 | 719 | 700 | 693 | 710 | 786 |
| Net profit | 57 | 68 | 22 | 25 | 11 | 21 | 22 | 29 |
| Net margin % | 5.3 | 7.0 | 2.9 | 3.5 | 1.6 | 3.1 | 3.1 | 3.7 |
| EPS (₹) | 2.05 | 2.44 | 0.78 | 0.92 | 0.4 | 0.77 | 0.79 | 1.06 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 2847 | 2985 | 2865 | 2797 | 3084 | 1768 |
| Net profit | 79 | 114 | 121 | 125 | 256 | 127 |
| Net margin % | 2.8 | 3.8 | 4.2 | 4.5 | 8.3 | 7.2 |
| EPS (₹) | 2.86 | 4.1 | 4.37 | 4.7 | 9.72 | 4.82 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 4.0% in Mar 2026; debt to equity is 0.27.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 4.0 | 5.9 | 6.7 | 8.8 |
| Return on capital % | 4.4 | 9.1 | 9.2 | 11.6 |
| EBITDA margin % | 6.5 | 10.1 | 9.8 | 9.1 |
| Net margin % | 2.8 | 3.8 | 4.2 | 4.4 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 0.6% | 10.1% |
| Profit CAGR | -14.0% | -9.0% |
4 · The owners
Who holds it, and are they adding?
Down 0.22 pts over 8 quarters.
Down 1.04 pts over 8 quarters.
Down 0.41 pts over 8 quarters.
+4 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 69.38 | 69.38 | 69.37 | 69.35 | 69.35 | 69.35 | 69.34 | 69.16 | -0.22 |
| FII | 1.97 | 2.48 | 1.63 | 1.6 | 1.6 | 1.15 | 0.69 | 0.93 | -1.04 |
| DII | 3.47 | 3.38 | 4.05 | 3.2 | 3.39 | 3.82 | 3.83 | 3.06 | -0.41 |
| Public | 25.18 | 24.76 | 24.94 | 25.85 | 25.66 | 25.68 | 26.14 | 26.84 | +1.66 |
Mutual fund holdings · Oct 2026
12 schemes hold this stock
8 the month before.
- ICICI Prudential Commodities Fund0.8% of NAV
- ICICI Prudential Multi Cap Fund0.35% of NAV
- Motilal Oswal Nifty Microcap 250 Index Fund0.16% of NAV
- ICICI Prudential Multi Asset Allocation Fund0.03% of NAV
- Bandhan Nifty Total Market Index Fund0.01% of NAV
- Motilal Oswal BSE 1000 Index Fund0.01% of NAV
- Groww Nifty Total Market Index Fund0.01% of NAV
- Angel One Nifty Total Market ETF0.01% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for LXCHEM are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about LXCHEM
What is the LXCHEM share price?
LXCHEM (LXCHEM) last closed at ₹153.85, up 2.02% on the day. Its 52-week range is ₹108.11 to ₹200.51.
What is the market cap of LXCHEM?
LXCHEM has a market capitalisation of about ₹4,185 crore. Its price-to-earnings ratio is 24.5.
How are LXCHEM's latest results?
LXCHEM reported revenue of ₹1,083 crore for Sep 2026, up 54.7% from a year earlier. Net profit was ₹57 crore (up 418.2% year on year). Return on equity was 4.0% in Mar 2026. Promoter holding was 69.16% in Sep 2026, down 0.22 points over 8 quarters.
Who owns LXCHEM?
As of Sep 2026, shareholding was: Promoter 69.16%, FII 0.93%, DII 3.06%, Public 26.84%.
How many mutual funds hold LXCHEM?
12 mutual fund schemes held LXCHEM in October 2026. That compares with 8 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 18 Jul 2025 · Final Dividend - Rs. 0.5
- 19 Jul 2024 · Final Dividend - Rs. 0.6
- 21 Jul 2023 · Final Dividend - Rs. 0.5
- 18 Jul 2022 · Final Dividend - Rs. 0.7
- 14 Jul 2021 · Final Dividend - Rs. 0.5
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.